tetraiodothyroacetic acid has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, YT; Davis, PJ; Incerpi, S; Lee, YS; Lin, HY; Liu, LF; Lu, YT; Pedersen, JZ; Shih, A; Wei, PL; Wu, HC; Yang, YSH | 1 |
1 other study(ies) available for tetraiodothyroacetic acid and cyclin d1
| Article | Year |
|---|---|
The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colorectal Neoplasms; Cyclin D1; Gene Expression Regulation, Neoplastic; Genes, myc; HCT116 Cells; HT29 Cells; Humans; Proliferating Cell Nuclear Antigen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 18S; Thyroid Hormones; Thyroxine | 2016 |